H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens

Biochem Biophys Res Commun. 2008 Jul 25;372(2):293-7. doi: 10.1016/j.bbrc.2008.05.057. Epub 2008 May 22.

Abstract

Using plasmid-based reverse genetics, we generated a molecularly altered virus, H5N1/PR8-5B19, containing modified HA and NA genes from A/Goose/Guangdong/1/96 (GS/GD/1/96). In the H5N1/PR8-5B19 virus, the HA cleavage site was modified to resemble that of low-pathogenic avian strains and a portion of the NA stalk region was replaced by the immunodominant 5B19 epitope of the S2 glycoprotein of murine hepatitis virus (MHV). H5N1/PR8-5B19 is not lethal to embryonated eggs or chickens. Chickens immunized with the H5N1/PR8-5B19 inactivated vaccine produced high levels of HI antibody and a measurable antibody response against the MHV 5B19 epitope, and were fully protected against subsequent challenge with different highly pathogenic H5N1 avian influenza viruses. H5N1/PR8-5B19 is therefore an attractive marker vaccine candidate, eliciting a strong, protective antibody response and enabling serological discrimination between vaccinated and wild-type virus-infected chickens.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral / biosynthesis
  • Antibodies, Viral / blood
  • Antibody Formation
  • Chickens / immunology*
  • Chickens / virology*
  • Glycoproteins / genetics
  • Glycoproteins / immunology
  • Hemagglutinin Glycoproteins, Influenza Virus / genetics
  • Hemagglutinin Glycoproteins, Influenza Virus / immunology*
  • Immunodominant Epitopes / genetics
  • Influenza A Virus, H5N1 Subtype / genetics
  • Influenza A Virus, H5N1 Subtype / immunology*
  • Influenza A Virus, H5N1 Subtype / physiology
  • Influenza Vaccines / genetics
  • Influenza Vaccines / immunology*
  • Influenza Vaccines / therapeutic use
  • Influenza in Birds / prevention & control*
  • Murine hepatitis virus / genetics
  • Murine hepatitis virus / immunology
  • Neuraminidase / genetics
  • Neuraminidase / immunology
  • Vaccination
  • Vaccines, DNA
  • Vaccines, Inactivated / genetics
  • Vaccines, Inactivated / immunology
  • Vaccines, Inactivated / therapeutic use
  • Viral Proteins / genetics
  • Viral Proteins / immunology
  • Virus Replication

Substances

  • Antibodies, Viral
  • Glycoproteins
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Immunodominant Epitopes
  • Influenza Vaccines
  • Vaccines, DNA
  • Vaccines, Inactivated
  • Viral Proteins
  • NA protein, influenza A virus
  • Neuraminidase